VYNE Therapeutics Inc. (VYNE) SEC filings
VYNE SEC filings moved a median of +0.94% by the close. VYNE SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the VYNE overview →
57 measured VYNE SEC filing events.
Where these VYNE SEC filings landedvs 55 measured VYNE SEC filing reactions
| Middle 50% of VYNE SEC filing reactions | -2.10% to +3.67% |
|---|---|
| Median reaction (to close) | +0.94% |
| Measured reactions | 55 |
Point-in-time · zero look-ahead
Half of the 55 VYNE SEC filing events with a measured close landed between -2.10% and +3.67%; 64% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K VYNE Therapeutics Inc. For: Jul 21 | SEC filing · Form 8-K | +5.00% | +13.87% | |
| Form 8-K VYNE Therapeutics Inc. For: Jul 16 | SEC filing · Form 8-K | +2.84% | +4.91% | |
| Form 8-K VYNE Therapeutics Inc. For: Jul 14 | SEC filing · Form 8-K | +2.46% | +9.38% | |
| Form 8-K VYNE Therapeutics Inc. For: Jul 10 | SEC filing · Form 8-K | +0.85% | +0.39% | |
| Form EFFECT VYNE Therapeutics Inc. | SEC filing · Form EFFECT | +0.11% | -1.67% | |
| Form ARS VYNE Therapeutics Inc. For: Dec 31 | SEC filing · Form ARS | -1.69% | +0.02% | |
| Form S-4/A VYNE Therapeutics Inc. | SEC filing · Form S-4 | +0.63% | -2.10% | |
| Form 8-K VYNE Therapeutics Inc. For: May 21 | SEC filing · Form 8-K | +0.00% | +1.53% | |
| Form 10-Q VYNE Therapeutics Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.39% | +0.94% | |
| Form S-4/A VYNE Therapeutics Inc. | SEC filing · Form S-4 | +0.00% | +0.94% | |
| Form S-4 VYNE Therapeutics Inc. | SEC filing · Form S-4 | -1.65% | +1.00% | |
| Form 8-K VYNE Therapeutics Inc. For: Mar 11 | SEC filing · Form 8-K | — | -2.10% | |
| Form 10-K VYNE Therapeutics Inc. For: Dec 31 | SEC filing · Form 10-K | -3.53% | +1.44% | |
| Form 8-K VYNE Therapeutics Inc. For: Jan 30 | SEC filing · Form 8-K | +1.80% | +3.10% | |
| Form 8-K VYNE Therapeutics Inc. For: Dec 17 | SEC filing · Form 8-K | -3.49% | -14.29% | |
| Form 8-K VYNE Therapeutics Inc. For: Dec 12 | SEC filing · Form 8-K | +0.00% | -3.85% | |
| Form ARS VYNE Therapeutics Inc. For: Dec 31 | SEC filing · Form ARS | +3.54% | — | |
| Form DEF 14A VYNE Therapeutics Inc. For: Dec 12 | SEC filing · Form DEF | +3.54% | — | |
| Form 10-Q VYNE Therapeutics Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.67% | -2.14% | |
| Form 8-K VYNE Therapeutics Inc. For: Nov 06 | SEC filing · Form 8-K | -1.39% | +2.44% | |
| Form 8-K VYNE Therapeutics Inc. For: Sep 11 | SEC filing · Form 8-K | +0.97% | -1.39% | |
| Form 10-Q VYNE Therapeutics Inc. For: Jun 30 | SEC filing · Form 10-Q | +2.91% | +3.18% | |
| Form 8-K VYNE Therapeutics Inc. For: Aug 11 | SEC filing · Form 8-K | -0.89% | +0.69% | |
| Form 8-K VYNE Therapeutics Inc. For: Jul 30 | SEC filing · Form 8-K | +2.26% | +0.68% | |
| Form 10-Q VYNE Therapeutics Inc. For: Mar 31 | SEC filing · Form 10-Q | +1.57% | +2.36% | |
| Form 8-K VYNE Therapeutics Inc. For: May 08 | SEC filing · Form 8-K | -2.83% | -7.80% | |
| Form 10-K VYNE Therapeutics Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -3.52% | |
| Form 8-K VYNE Therapeutics Inc. For: Mar 06 | SEC filing · Form 8-K | — | +0.43% | |
| Form 8-K VYNE Therapeutics Inc. For: Jan 13 | SEC filing · Form 8-K | -2.64% | -11.18% | |
| Form 8-K VYNE Therapeutics Inc. For: Dec 23 | SEC filing · Form 8-K | +1.73% | -1.15% | |
| Form S-8 VYNE Therapeutics Inc. | SEC filing · Form S-8 | -1.67% | +4.17% | |
| Form 8-K VYNE Therapeutics Inc. For: Dec 12 | SEC filing · Form 8-K | +0.00% | +8.47% | |
| Form ARS VYNE Therapeutics Inc. For: Dec 31 | SEC filing · Form ARS | +1.21% | -3.00% | |
| Form DEF 14A VYNE Therapeutics Inc. For: Dec 12 | SEC filing · Form DEF | +1.21% | -3.00% | |
| Form 10-Q VYNE Therapeutics Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.64% | +0.32% | |
| Form 8-K VYNE Therapeutics Inc. For: Nov 07 | SEC filing · Form 8-K | +1.78% | +0.80% | |
| Form 8-K VYNE Therapeutics Inc. For: Sep 12 | SEC filing · Form 8-K | +0.00% | -3.24% | |
| Form 10-Q VYNE Therapeutics Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.58% | +7.51% | |
| Form 8-K VYNE Therapeutics Inc. For: Aug 14 | SEC filing · Form 8-K | +0.00% | +2.37% | |
| Form 10-Q VYNE Therapeutics Inc. For: Mar 31 | SEC filing · Form 10-Q | +3.37% | +0.00% | |
| Form 8-K VYNE Therapeutics Inc. For: May 09 | SEC filing · Form 8-K | +0.00% | -4.33% | |
| Form EFFECT VYNE Therapeutics Inc. | SEC filing · Form EFFECT | +0.00% | -3.83% | |
| Form 10-K VYNE Therapeutics Inc. For: Dec 31 | SEC filing · Form 10-K | +2.38% | +8.57% | |
| Form S-3 VYNE Therapeutics Inc. | SEC filing · Form S-3 | +2.38% | +8.57% | |
| Form S-8 VYNE Therapeutics Inc. | SEC filing · Form S-8 | +2.38% | +8.57% | |
| Form 8-K VYNE Therapeutics Inc. For: Feb 29 | SEC filing · Form 8-K | -1.29% | -4.29% | |
| Form 8-K VYNE Therapeutics Inc. For: Dec 29 | SEC filing · Form 8-K | +0.89% | +2.21% | |
| Form 8-K VYNE Therapeutics Inc. For: Dec 11 | SEC filing · Form 8-K | +0.00% | +2.97% | |
| Form S-8 VYNE Therapeutics Inc. | SEC filing · Form S-8 | +0.00% | +2.97% | |
| Form EFFECT VYNE Therapeutics Inc. | SEC filing · Form EFFECT | -2.83% | +3.08% | |
| Form D VYNE Therapeutics Inc. | SEC filing · Form D | +0.00% | +0.00% | |
| Form 10-Q VYNE Therapeutics Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.32% | +10.48% | |
| Form 8-K VYNE Therapeutics Inc. For: Nov 13 | SEC filing · Form 8-K | +0.32% | +10.48% | |
| Form ARS VYNE Therapeutics Inc. For: Dec 31 | SEC filing · Form ARS | +1.15% | +4.69% | |
| Form DEF 14A VYNE Therapeutics Inc. For: Dec 13 | SEC filing · Form DEF | +1.15% | +4.69% | |
| Form S-3 VYNE Therapeutics Inc. | SEC filing · Form S-3 | +1.15% | +4.69% | |
| Form 8-K VYNE Therapeutics Inc. For: Oct 27 | SEC filing · Form 8-K | -0.95% | -12.06% |
Keep exploring
More VYNE: earnings → · analyst actions → · VYNE overview →